The global contrast media injectors market is expected to reach USD 2.0 billion by 2030, registering a CAGR of 7.4% during the forecast period, according to a new report by Grand View Research, Inc. The market is expected to grow because of the rising demand for minimally invasive surgical procedures, along with the increasing usage of consumables for several diagnostic procedures, which are supporting the market growth of contrast media injectors.

COVID-19 had a significant impact on the contrast media injector market, in 2019, with around a 30-40% reduction in sales due to the imposed lockdown and rapid decline in imaging case volume. However, the market is expected to return to peak levels of 2019 by 2022. This is due to the launch of COVID-19 vaccines and ease in restrictions, import & export of raw materials have resumed; therefore, the market is expected to grow at a significant rate over the forecast period.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/contrast-media-injectors-market

Technological advancements such as IT-enabled solutions for contrast media injectors, along with growing demand for minimally invasive surgical procedures, are expected to boost the market during the coming years. Furthermore, the large number of intraoperative imaging procedures being performed has further enhanced the demand for these injectors, propelling the market growth.

Contrast Media Injectors Market Report Highlights

• By product, injector systems accounted for the largest market share of 60.9% in 2022, due to its growing application in the diagnosis and treatment of vascular disease, cancer, and others
• By type, single head injectors accounted for the largest market share of 44.0% in 2022, because of their wide usage in the field of angiography, CT, and MRI as well these products are inexpensive
• Based on the application, the radiology segment dominated the market with around 47.1% of the revenue share in 2022, because it is the primary procedure used for the diagnosis of several chronic diseases
• Based on the end use, the hospitals segment dominated the market with around 68.2% of the revenue share in 2022, due to the fact that these facilities are primary users of the contrast media injectors because of their need to record the rhythm & electrical activity and evaluate the results in detail for clinical & research purposes
• Asia Pacific contrast media injectors market is expected to witness the fastest growth rate at a CAGR of 8.5% over the forecast period. Factors that can be attributed to market growth include the growing geriatric population and an increasing number of surgeries

Contrast Media Injectors Market Segmentation

Grand View Research has segmented the global contrast media injectors market on the basis of product, type, application, end use, and region:

Contrast Media Injectors Product Outlook (Revenue USD Million; 2016 - 2030)

• Injector Systems
  • CT injector systems
  • MRI injector systems
  • Cardiovascular/angiography injector systems
• Consumables
  • Tubing
  • Syringe
  • Others

Contrast Media Injectors Type Outlook (Revenue USD Million; 2016 - 2030)

• Single Head Injectors
• Dual-Head Injectors
• Syringeless Injectors

Contrast Media Injectors Application Outlook (Revenue USD Million; 2016 - 2030)

• Radiology
• Interventional Cardiology
• Interventional Radiology

Contrast Media Injectors End Use Outlook (Revenue USD Million; 2016 - 2030)

• Hospitals
• Diagnostics Centers
• Ambulatory Surgery Centers

List of Key Players in Contrast Media Injectors Market

• Bayer HealthCare LLC
• Bracco Group
• Ulrich Medical
• Guerbet Group
• Medtron AG
• Nemoto Kyorindo Co., Ltd.
• Hong Kong Medi Co Limited

Browse Full Report Here: https://www.grandviewresearch.com/industry-analysis/contrast-media-injectors-market